Potassium (tert-Butoxymethyl)trifluoroborate
Product Information
Molecular Formula
C5H11BF3KO
Molecular Weight
194.044
Description
Potassium (tert-Butoxymethyl)trifluoroborate is a highly versatile and intriguing compound that stands as a prominent figure in the biomedical industry. Its multifaceted nature enables it to serve as a valuable reagent in the intricate synthesis of pharmaceutical compounds. By offering a helping hand in the creation of medicinal field, this product spearheads the quest to combat an array of ailments that plague humanity, ranging from the cancer to inflammation and neurological disorders.
Synonyms
Potassium tert-butoxymethyltrifluoroborate; tert-butoxymethyltrifluoroborate potassium salt
IUPAC Name
potassiumtrifluoro-[(2-methylpropan-2-yl)oxymethyl]boranuide
SMILES
[B-](COC(C)(C)C)(F)(F)F.[K+]
InChI
InChI=1S/C5H11BF3O.K/c1-5(2,3)10-4-6(7,8)9/h4H2,1-3H3/q-1+1
InChI Key
XBEPCFNGTDJTIY-UHFFFAOYSA-N
Melting Point
292-296 °C
Flash Point
Not applicable
Purity
95%
Safety Information
Hazards
H302
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
2
Exact Mass
194.0492111 g/mol
Monoisotopic Mass
194.0492111 g/mol
Topological Polar Surface Area
9.2Ų
Heavy Atom Count
11
Formal Charge
0
Complexity
109
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021257353-A1 | Plasma kallikrein inhibitors | 2020-06-16 |
| AU-2017219627-A1 | Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors | 2016-02-15 |
| CA-3014644-A1 | Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors | 2016-02-15 |
| EP-3416969-A1 | Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors | 2016-02-15 |
| WO-2017142881-A1 | Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors | 2016-02-15 |
| EP-3416969-B1 | Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors | 2016-02-15 |
| AU-2017219627-B2 | Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors | 2016-02-15 |
| US-2021188870-A1 | Fused 1,4-oxazepines and related analogs as bet bromodomain inhibitors | 2016-02-15 |
| JP-6967522-B2 | Fusion 1,4-oxazepine as a BET bromodomain inhibitor and related analogs | 2016-02-15 |
| JP-6855477-B2 | Heteroarylcarboxamide derivative as a plasma kallikrein inhibitor | 2015-10-27 |
